Trials / Completed
CompletedNCT01946971
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)
Lansoprazole in Preterm Infants With Gastroesophageal Reflux
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Not accepted
Summary
This study is crossover study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lansoprazole | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2013-09-20
- Last updated
- 2014-11-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01946971. Inclusion in this directory is not an endorsement.